An effect of steroidal hormones up)on cerebral metabolism was suggested by Selye's (1) observationl that steroids possess anesthetic properties when administered to experimental animals. Gordan and Elliott (2) ( 17, 18) , for the determination of cerebral blood flow in man. An estimation of the rate of cerebral blood flow permiiits a computation of the rate of utilization or production by the brain of any substance which canl be accurately analyzed in 1loo00.
(From the Di-visionis of Medicine anid Neuirological Sutrgery, Unizversity of Califor-ijia School of Medicinie, San1 Franzcisco) (Submitted for publication August 8, 1950 ; accepted, November 13, 1950) I NTRODUCTION An effect of steroidal hormones up)on cerebral metabolism was suggested by Selye's (1) observationl that steroids possess anesthetic properties when administered to experimental animals. Gordan and Elliott (2) subsequently showed that certain steroids inhibit glucose utilization by rat brain in vitro and that their comparative inhibitory activity parallels their reported anesthetic potency. These observations were confirmiie(d by Hayano, Schiller, and Dorfman (3). The p)ossibility that steroidal inhibition of cerebral oxidative processes may be a physiological occurrence was demonstrated by Eisenberg, Gordan, and Elliott (4, 5) .
They found that deprivation of gonadal steroids by castration produces an increase in the rate of glucose utilization by rat brain and that the in vivo administration of testosterone, as well as other steroids with the anidrostene nucletus, )revents the characteristic rise. Desoxycorticosterone was the most potent of the steroidal compounds tested.
Evidence of an in vizvo action of steroidlal hormones on cerebral ftunctions in manl miiay be inferred fromii the observations of Pinicts and( Hoagland (6) (7) (8) (9) ( 17, 18) , for the determination of cerebral blood flow in man. An estimation of the rate of cerebral blood flow permiiits a computation of the rate of utilization or production by the brain of any substance which canl be accurately analyzed in 1loo00.
A steroidal compotund well adapted for use in short-term studies in miian is also available in the potent, water-soluble desoxycorticosterone glucoside (DCG). ' The conjunction of a workable miethod for the estimationi of the rate of cerebral blood flow and an active, water-soluble steroid has made feasible a measureml-ent of steroidal effects on the metabolism of the human brain inv aiVo.
METHOD
Cerebral blood flow (CBF) and cerebral metabolic rate (CMR) were estimated in 15 human subjects by the original nitrous oxide method of Kety and Schmidt (17, 18) . Of the patients studied, seven had no endocrine disease, one had mild diabetes mellitus controlled by diet alone, two had been castrated for prostatic carcinoma, one represented Klinefelter's syndrome with hypoleydigism, and four had chromophobe adenomas with secondary hypogonadism. The subjects received no medications for 24 hours or more before the study and hormonal medications had been withheld for the preceding two or more weeks.
With the fasting subject supine, needles were inserted into the jugular bulb and either the femoral or internal carotid artery and connected to heparinized manifolds as described by Kety and Schmidt. In order to avoid the effects of emotional stimuli, as stressed by Scheinberg and Stead (19) , no further procedures were undertaken until a steady state was achieved as determined by stable cardiac rate and blood pressure. In 14 of the 15 patients, two determinations of the rate of cerebral blood flow were made consecutively. Twenty minutes were allowed to elapse after the control determination to permit expiration of nitrous oxide, and a second blood blank for nitrous oxide was obtained in each case. Prior to proceeding with the second cerebral blood flow determination, specimens for control glucose levels of arterial, cerebral venous and, in seven cases, peripheral (antecubital) venous blood were obtained. All of these were drawn simultaneously at two-minute intervals until three separate sets of control specimens had been obtained.
Immediately after the third set of control samples for glucose determination were taken, 50 mgm. of DCG were injected intravenously and a second determination of the cerebral blood flow was made without delay. Blood sugar values were determined on aliquots of the simultaneously drawn experimental specimens of arterial and cerebral venous blood throughout the procedure for comparison with the previously drawn control specimens. Following completion of the second cerebral blood flow determination, two additional sets of specimens were obtained for analysis of sugar levels at three-minute intervals. When peripheral (antecubital) venous specimens were obtained, they were drawn simultaneously with the arterial and cerebral venous specimens. During each cerebral blood flow determination, arterial and cerebral venous oxygen and carbon dioxide content was determined upon separate specimens consisting of 5 cc. of blood drawn immediately before the first CBF sample and an equal amount drawn into the same syringe directly following the five-minute CBF specimen.
Blood oxygen and carbon dioxide analyses were made in duplicate by the manometric technique of Van Slyke and Neill (20) , as modified by Kety and Schmidt (18) . Blood sugar content was determined by the iodometric titration method of Somogyi (21, 22) and yielded results reproducible within 1 per cent. In accordance with the injunction of Somogyi (23) Experimental data are presented in Table I . For each function measured, the mean value and the standard deviation of the mean is included.
Striking and rapid effects were noted upon blood sugar levels following administration of 50 mgm. of DCG. Uniformly, the cerebral venous glucose concentration rose significantly-4h eight instances above the arterial level-effecting in 13 of the 15 cases a reduction in the cerebral arteriovenous glucose difference. While the individual changes in the arterial and peripheral (antecubital) venous blood sugar concentrations were inconsistent and not marked, a small, but statistically significant (p < 0.01), rise occurred in both the mean arterial and the mean antecubital venous blood sugar concentrations following the administration of DCG. Examples of the glucose concentration curves are shown in Figures 1 and  2 . It should be noted that the changes in glucose concentration occurred without alteration in the rate of cerebral blood flow. Figure 3 An increase in the sugar concentration of the 'As performed, the Somogyi method is a measure of reducing substance content, almost exclusively monosaccharides. Subsequent to the preparation of this report, we have found that the bulk of the reducing substance liberated into the cerebral venous blood is non-fermentable, and preliminary attempts at identification suggest galactose. cerebral venous blood above that of arterial blood obtained simultaneously indicates liberation of sugar by the brain. From these observations alone, however, it is not possible to conclude that there is not also an alteration of the cerebral utilization of glucose.
From the present data, the mechanism and specificity of this effect may be only conjectured. Of the several possible sources for the sugar liberated from the brain following DCG, a derivation from intracellular glycogen stores may be considered. Kerr and Ghantus (25) have demonstrated sufficient quantities of glycogen in the brains of dogs and rabbits to account for the amount of sugar "liberated" following injection of DCG. The presence of some endogenous substrate in human brain which can be utilized for cerebral oxidative processes in vitro is suggested by Elliott, Sutherland, and Boldrey (26) . They found that the oxygen consumption of slices of human cerebral cortex was maintained for a significantly longer period in the absence of a glucose substrate than was the oxygen consumption of rat brain, which dropped off rapidly. If this substrate is glycogen, the glycogenolytic potentiality of desoxycorticosterone reported by Verzar and Wenner (27) CMRo, or CMRco, was observed, indicating that desoxycorticosterone glucoside does not influence the aerobic phase of cerebral energy metabolism as an immediate general effect, although it may alter the substrate. However, it is interesting that the cerebral metabolic rate was diminished following administration of DCG in all but one ortho-steroidal subject and that no change or only a slight increase in cerebral metabolic rate was apparent in all hyposteroidal subjects. Until the individual groups are expanded, it is not possible to establish the significance of this observation. In this connection it is recognized that the data included in the present paper group together observations made upon individuals with divergent endocrine states. The data suggest that enlargement of the groups may eliminate some of the variability due to the lumping together of non-comparable individuals. The fact that the standard deviations of the mean in this study are somewhat greater than those reported by other workers may, in part, be explained on this basis.
While the arterio-venous sugar difference reflected in the cerebral circulation is altered, no such change occurs in the peripheral arteriovenous glucose difference, suggesting the absence of an immediate effect of desoxycorticosterone glucoside upon the glucose metabolism of the muscular tissues of the forearm. The small but significant rise in the mean arterial glucose concentration following administration of DCG might be accounted for by liberation of glucose from other sources, possibly the liver. 4. Preliminary data suggest a different response to DCG between individuals with normal and deficient steroidal status.
5. The mean arterial blood pressure, cardiac rate, and rate of cerebral blood flow were not altered by DCG.
